Adrian Li

Adrian Li has a diverse work experience in various industries. Adrian started their career at Nansha Biologics (HK) Limited as a Research and Development Intern in 2017. In 2018, Adrian worked at GSK as an Industrial Placement, where they managed an independent research project focused on the role of monocytes in immune activation in rheumatoid arthritis disease. Adrian also collaborated with research teams and gained experience with technical assays and data analysis. Adrian then joined Phoenix Property Investors in 2021 as an Investment Intern. Currently, Adrian is working at Animoca Brands, starting in 2022, initially as a Digital Asset Analyst and later promoted as Digital Asset Associate in 2023.

Adrian Li pursued their education at the University of Bath from 2016 to 2020, where they obtained a Master of Pharmacology (MPharm) degree with a specialization in Pharmacology. In May 2021, they also earned a certification in passing the CFA Level 2 from the CFA Institute.